Guard Therapeutics International AB (FRA:5LH0) Cyclically Adjusted FCF per Share: €-2.51 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5LH0 Guard Therapeutics International AB FRA:5LH0
18 GF Score
Price €0.12
! 1 Warning Sign
View Full Analysis

What is Guard Therapeutics International AB Cyclically Adjusted FCF per Share?

Guard Therapeutics International AB FRA:5LH0 +0.66% 18 Cyclically Adjusted FCF per Share is €-2.51 as of Mar. 2026. GuruFocus rates FRA:5LH0 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Guard Therapeutics International AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.041. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-2.51 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 20.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Guard Therapeutics International AB was 20.20% per year. The lowest was 9.00% per year. And the median was 14.60% per year.

As of today (2026-08-04), Guard Therapeutics International AB's current stock price is €0.122. Guard Therapeutics International AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-2.51. Guard Therapeutics International AB's Cyclically Adjusted Price-to-FCF of today is .


Guard Therapeutics International AB  (FRA:5LH0) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Guard Therapeutics International AB Cyclically Adjusted FCF per Share Related Terms


Guard Therapeutics International AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Guard Therapeutics International AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guard Therapeutics International AB Cyclically Adjusted FCF per Share Chart

Guard Therapeutics International AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.32 -17.83 -19.57 -14.73 -2.20

Guard Therapeutics International AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.41 -12.32 -10.97 -2.20 -2.51

FRA:5LH0 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Guard Therapeutics International AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guard Therapeutics International AB Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guard Therapeutics International AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Guard Therapeutics International AB's Cyclically Adjusted Price-to-FCF falls into.


FRA:5LH0
18GF Score
Guard Therapeutics International AB FRA:5LH0
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guard Therapeutics International AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guard Therapeutics International AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.041/133.5600*133.5600
=-0.041

Current CPI (Mar. 2026) = 133.5600.

Guard Therapeutics International AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -9.425 101.019 -12.461
201609 -11.058 101.138 -14.603
201612 -16.767 102.022 -21.950
201703 -5.135 102.022 -6.722
201706 -11.544 102.752 -15.005
201709 -5.179 103.279 -6.697
201712 -3.795 103.793 -4.883
201803 -2.741 103.962 -3.521
201806 -2.861 104.875 -3.644
201809 -1.556 105.679 -1.967
201812 -1.722 105.912 -2.172
201903 -1.216 105.886 -1.534
201906 -0.378 106.742 -0.473
201909 -0.447 107.214 -0.557
201912 -0.264 107.766 -0.327
202003 -0.199 106.563 -0.249
202006 -0.284 107.498 -0.353
202009 -0.332 107.635 -0.412
202012 -0.237 108.296 -0.292
202103 -0.188 108.360 -0.232
202106 -0.272 108.928 -0.334
202109 -0.686 110.338 -0.830
202112 -0.338 112.486 -0.401
202203 -0.218 114.825 -0.254
202206 -0.268 118.384 -0.302
202209 -0.400 122.296 -0.437
202212 -0.391 126.365 -0.413
202303 -0.294 127.042 -0.309
202306 -0.312 129.407 -0.322
202309 -0.208 130.224 -0.213
202312 -0.148 131.912 -0.150
202403 -0.163 132.205 -0.165
202406 -0.158 132.716 -0.159
202409 -0.269 132.304 -0.272
202412 -0.145 132.987 -0.146
202503 -0.267 132.825 -0.268
202506 -0.113 133.699 -0.113
202509 -0.139 133.480 -0.139
202512 -0.085 133.390 -0.085
202603 -0.041 133.560 -0.041

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-2.51 mean?
Guard Therapeutics International AB (FRA:5LH0) has a Cyclically Adjusted FCF per Share of €-2.51 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Guard Therapeutics International AB and its competitors.
Is Guard Therapeutics International AB's Cyclically Adjusted FCF per Share too high?
Guard Therapeutics International AB's current Cyclically Adjusted FCF per Share is €-2.51. Overall, Guard Therapeutics International AB has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Guard Therapeutics International AB's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Guard Therapeutics International AB's Cyclically Adjusted FCF per Share of €-2.51 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Guard Therapeutics International AB and its competitors. Guard Therapeutics International AB's current Cyclically Adjusted FCF per Share is €-2.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guard Therapeutics International AB stock overvalued right now?
Guard Therapeutics International AB (FRA:5LH0) has a current Cyclically Adjusted FCF per Share of €-2.51. The current Cyclically Adjusted FCF per Share is €-2.51. Guard Therapeutics International AB's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Guard Therapeutics International AB (FRA:5LH0), the current Cyclically Adjusted FCF per Share is €-2.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guard Therapeutics International AB Business Description

Other Exchanges GUARD:Sweden
Address Scheelevagen 22, Lund, SWE, 223 63
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.
18GF Score

Get the complete analysis for FRA:5LH0

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.12
Price